References
- Bertram, J. R., Porath, A., Seitz, D., Kalant, H., Krishnamoorthy, A., Nickerson, J., Sidhu, A., Smith, A., & Teed, R. (2020). Canadian guidelines on cannabis use disorder among older adults. Canadian Geriatrics Journal: CGJ, 23(1), 135–142. https://doi.org/https://doi.org/10.5770/cgj.23.424
- Blanco, C., Hasin, D. S., Wall, M. M., Florez-Salamanca, L., Hoertel, N., Wang, S., Kerridge, B. T., & Olfson, M. (2016). Cannabis use and risk of psychiatric disorders: Prospective evidence from a US National Longitudinal Study. JAMA Psychiatry, 73(4), 388–395. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2015.3229
- Brezing, C. A., & Levin, F. R. (2018). The current state of pharmacological treatments for cannabis use disorder and withdrawal. Neuropsychopharmacology, 43(1), 173–194. https://doi.org/https://doi.org/10.1038/npp.2017.212
- Budney, A. J., Sofis, M. J., & Borodovsky, J. T. (2019). An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. European Archives of Psychiatry and Clinical Neuroscience, 269(1), 73–86. https://doi.org/https://doi.org/10.1007/s00406-018-0976-1
- Charilaou, P., Agnihotri, K., Garcia, P., Badheka, A., Frenia, D., & Yegneswaran, B. (2017). Trends of cannabis use disorder in the inpatient: 2002 to 2011. The American Journal of Medicine, 130(6), 678–687.e7. https://doi.org/https://doi.org/10.1016/j.amjmed.2016.12.035
- Dervaux, A. (2018). Consommation de cannabis et comorbidites psychiatriques (Cannabis use disorders and psychiatric comorbidities). La Revue du Praticien, 68(6), 670–674. https://www.ncbi.nlm.nih.gov/pubmed/30869262
- Eurich, D., Hanlon, J. G., Boisvenue, J. J., Meng, H., & Dyck, J. R. B. (2019). A description of medical cannabis use in Ontario. Canada. Cannabis and Cannabinoid Research, 4(2), 131–135. https://doi.org/https://doi.org/10.1089/can.2018.0036
- Eurich, D., Lee, C., Zongo, A., Minhas-Sandhu, J. K., Hanlon, J. G., Hyshka, E., & Dyck, J. (2020). Cohort study of medical cannabis authorisation and healthcare utilisation in 2014–2017 in Ontario. Journal of Epidemiology and Community Health, 74(3), 299–304. https://doi.org/https://doi.org/10.1136/jech-2019-212438
- Gage, S. H., Hickman, M., & Zammit, S. (2016). Association between cannabis and psychosis: Epidemiologic evidence. Biological Psychiatry, 79(7), 549–556. https://doi.org/https://doi.org/10.1016/j.biopsych.2015.08.001
- Garrett, C., & Doherty, A. (2014). Diabetes and mental health. Clinical Medicine, 14(6), 669–672. https://doi.org/https://doi.org/10.7861/clinmedicine.14-6-669
- Goulet-Stock, S., Rueda, S., Vafaei, A., Ialomiteanu, A., Manthey, J., Rehm, J., & Fischer, B. (2017). Comparing medical and recreational cannabis users on socio-demographic, substance and medication use, and health and disability characteristics. European Addiction Research, 23(3), 129–135. https://doi.org/https://doi.org/10.1159/000475987
- Gunn, R., Jackson, K., Borsari, B., & Metrik, J. (2019). A longitudinal examination of daily patterns of cannabis and alcohol co-use among medicinal and recreational veteran cannabis users. Drug and Alcohol Dependence, 205, 107661. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2019.107661
- Ksir, C., & Hart, C. L. (2016). Cannabis and psychosis: A critical overview of the relationship. Current Psychiatry Reports, 18(2), 12. https://doi.org/https://doi.org/10.1007/s11920-015-0657-y
- Loflin, M., Earleywine, M., & Bonn-Miller, M. (2017). Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD. Addictive Behaviors, 68, 18–23. https://doi.org/https://doi.org/10.1016/j.addbeh.2017.01.008
- Loflin, M. J. E., Kiluk, B. D., Huestis, M. A., Aklin, W. M., Budney, A. J., Carroll, K. M., D’Souza, D. C., Dworkin, R. H., Gray, K. M., Hasin, D. S., Lee, D. C., Le Foll, B., Levin, F. R., Lile, J. A., Mason, B. J., McRae-Clark, A. L., Montoya, I., Peters, E. N., Ramey, T., … Strain, E. C. (2020). The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug and Alcohol Dependence, 212, 107993. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2020.107993
- Lucatch, A. M., Coles, A. S., Hill, K. P., & George, T. P. (2018). Cannabis and mood disorders. Current Addiction Reports, 5(3), 336–345. https://doi.org/https://doi.org/10.1007/s40429-018-0214-y
- Mannes, Z. L., Ferguson, E. G., Burrell, L. E., Cook, R. L., & Ennis, N. (2018). Brief report: The association between recreational versus therapeutic marijuana use on hazardous alcohol consumption and alcohol-associated behavioral consequences among adults living with HIV in Florida. Harm Reduction Journal, 15(1), 61. https://doi.org/https://doi.org/10.1186/s12954-018-0266-2
- Patel, J. M. R. (2020). Cannabis use disorder (T. I. F. S. Publishing, Ed.). StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK538131/
- Patel, R. S., Mekala, H. M., & Tankersley, W. E. (2019). Cannabis use disorder and epilepsy: A cross-national analysis of 657 072 hospitalized patients. The American Journal on Addictions, 28(5), 353–360. https://doi.org/https://doi.org/10.1111/ajad.12898
- Pinto, J. V., Medeiros, L. S., Santana da Rosa, G., Santana de Oliveira, C. E., Crippa, J. A. S., Passos, I. C., & Kauer-Sant’Anna, M. (2019). The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression. Neuroscience and Biobehavioral Reviews, 101, 78–84. https://doi.org/https://doi.org/10.1016/j.neubiorev.2019.04.004
- Roy-Byrne, P., Maynard, C., Bumgardner, K., Krupski, A., Dunn, C., West, I. I., Donovan, D., Atkins, D. C., & Ries, R. (2015). Are medical marijuana users different from recreational users? The view from primary care. The American Journal on Addictions, 24(7), 599–606. https://doi.org/https://doi.org/10.1111/ajad.12270
- Sahlem, G. L., Tomko, R. L., Sherman, B. J., Gray, K. M., & McRae-Clark, A. L. (2018). Impact of cannabis legalization on treatment and research priorities for cannabis use disorder. International Review of Psychiatry (Abingdon, England), 30(3), 216–225. https://doi.org/https://doi.org/10.1080/09540261.2018.1465398
- Salas-Wright, C. P., Carbone, J. T., Holzer, K. J., & Vaughn, M. G. (2019). Prevalence and correlates of cannabis poisoning diagnosis in a national emergency department sample. Drug and Alcohol Dependence, 204, 107564. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2019.107564
- Subbaraman, M. S., & Kerr, W. C. (2018). Alcohol use and risk of related problems among cannabis users is lower among those with medical cannabis recommendations, though not due to health. Journal of Studies on Alcohol and Drugs, 79(6), 935–942. https://www.ncbi.nlm.nih.gov/pubmed/30573025 https://doi.org/https://doi.org/10.15288/jsad.2018.79.935
- Sznitman, S. R. (2017). Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? The International Journal on Drug Policy, 42, 15–21. https://doi.org/https://doi.org/10.1016/j.drugpo.2016.11.010
- Turna, J., Balodis, I., Munn, C., Van Ameringen, M., Busse, J., & MacKillop, J. (2020). Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users. Comprehensive Psychiatry, 102, 152188. https://doi.org/https://doi.org/10.1016/j.comppsych.2020.152188
- Wang, J., Willis, K., Barson, E., & Smallwood, N. (2021). The complexity of mental health care for people with COPD: A qualitative study of clinicians’ perspectives. NPJ Primary Care Respiratory Medicine, 31(1), 40. https://doi.org/https://doi.org/10.1038/s41533-021-00252-w
- Ware, M. A., Martel, M. O., Jovey, R., Lynch, M. E., & Singer, J. (2018). A prospective observational study of problematic oral cannabinoid use. Psychopharmacology, 235(2), 409–417. https://doi.org/https://doi.org/10.1007/s00213-017-4811-6
- Wilkinson, S. T., Yarnell, S., Radhakrishnan, R., Ball, S. A., & D’Souza, D. C. (2016). Marijuana legalization: Impact on physicians and public health. Annual Review of Medicine, 67, 453–466. https://doi.org/https://doi.org/10.1146/annurev-med-050214-013454
- Yeung, M. E. M., Weaver, C. G., Janz, K., Haines-Saah, R., & Lang, E. (2020). Clearing the air: A study of cannabis-related presentations to urban Alberta emergency departments following legalization. CJEM, 22(6), 776–778. https://doi.org/https://doi.org/10.1017/cem.2020.384
- Zehra, A., Burns, J., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G. J. (2018). Cannabis addiction and the brain: A review. Journal of Neuroimmune Pharmacology, 13(4), 438–452. https://doi.org/https://doi.org/10.1007/s11481-018-9782-9